Background The COVID-19 pandemic, caused by the novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has substantially impacted healthcare utilization worldwide…

This study describes demographics, thrombotic and bleeding events, mortality, and
anticoagulant use among hospitalized patients with COVID-19 in the United States. Premier …

Nirmatrelvir (coadministered with ritonavir as PAXLOVID TM ) reduces the risk of COVID-19-related
hospitalizations and all-cause death in individuals with mild-to-moderate COVID-19 …

Background Several underlying medical conditions have been reported to be associated with
an increased risk of coronavirus disease 2019 (COVID-19) and related hospitalization and …

Objectives To quantify direct costs and healthcare resource utilisation (HCRU) associated
with acute COVID-19 in adults in England. Design Population-based retrospective cohort …

Objective To create case definitions for confirmed COVID-19 diagnoses, COVID-19
vaccination status and three separate definitions of high risk of severe COVID-19, as well as to …

Background Pregnant women with coronavirus disease 2019 (COVID-19) may be at greater
risk of poor maternal and pregnancy outcomes. This retrospective analysis reports clinical …

Aims This retrospective analysis of the Optum Clinformatics Data Mart database evaluated
US patient characteristics, healthcare resource utilization (HCRU), costs, and treatment …

Background The United States has experienced high COVID- 19 case counts, hospitalizations,
and death rates. This retrospective analysis reports changing trends in the demographics …

Introduction We compared hospitalization outcomes of young children hospitalized with
COVID-19 to those hospitalized with influenza in the United States. Methods Patients aged 0-<5 …